The AB-Biotics Personalized Medicine Platform (NEUROFARMAGEN) Increases Psychiatric Treatment Efficacy by 67%

10/06/2019

AB-Biotics attended for the first time to ESPGHAN 2019 Annual Meeting (The European Society for Paediatric Gastroenterology Hepatology and Nutrition) held last week in Glasgow (Scottland). ESPGHAN is a multi-professional organization whose...

20/03/2019

As reported by the company, it increased its turnover by 65% in 2018 at the end of the year with revenues of 11,8 million euros. The company's EBITDA reached 2 million euros...

24/09/2018

The leading biotechnology company AB Biotics and the International University of Barcelona (UIC Barcelona) have signed a collaboration agreement for the next three years with the aim of developing investigation projects that...

13/08/2018

By incorporating Josep Maria Echarri, Managing Director of Inveready Asset Management, and Joan Ramón Ramos, a renowned economist with a long trajectory in the world of business consultancy, AB Biotics completes the...

05/07/2018

- Yesterday’s Annual General Meeting of Shareholders named the members of the new Board of Directors - The founding partners are now joined by Luís Sánchez-Lafuente and four board members from Kaneka...